Welcome to our dedicated page for Cooper SEC filings (Ticker: COO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cooper Companies, Inc. filings document a Nasdaq-listed medical device company with common stock trading under the symbol COO. Its regulatory disclosures include Form 8-K reports on quarterly results, board and officer changes, annual meeting voting results, and material definitive agreements, including amendments to term loan arrangements.
Proxy materials describe director elections, board committee matters, executive compensation, shareholder proposals, and governance practices. Together, the filings record operating and financial disclosures for CooperVision and CooperSurgical, capital structure information, debt arrangements, stockholder voting mechanics, and risk and governance topics relevant to the company’s contact lens, fertility, and women’s healthcare businesses.
Cooper Companies’ President & CEO, who is also a director, received a grant of stock options covering 184,069 shares of common stock on 12/10/2024. The options have an exercise price of $99.08 and expire on 12/10/2034.
The Form 4/A states it is filed solely to correct the number of shares issuable upon exercise of this previously reported option grant. The options vest at 25% per year over four years beginning on the grant date, and the full 184,069 options are reported as directly beneficially owned.
The Cooper Companies, Inc. amended its debt agreements to adjust terms on its term loan and revolving credit facilities. The company extended the maturity of $950 million of term loans to February 3, 2031, while keeping the maturity date for the remaining $550 million of term loans unchanged.
The amendment also removes the prior credit spread adjustment and raises the cap on incremental term loans to the greater of $1.365 billion and 100% of consolidated EBITDA. Pricing on the term loans can now be based either on the company’s non-credit enhanced, senior unsecured long-term debt ratings or on its consolidated net indebtedness to consolidated EBITDA ratio.
A related amendment to the revolving credit agreement aligns its provisions with the revised term loan agreement, including the removal of credit spread adjustments.
Cooper Companies director Colleen Jay reported exercising stock options and increasing her direct shareholdings. On 01/12/2026, she exercised 7,064 stock options with an exercise price of $39.4 per share, converting them into the same number of shares of Common Stock.
Following this transaction, she directly held 36,585 shares of Common Stock. The exercised stock option award was fully used, leaving 0 derivative securities of that option grant outstanding.
Cooper Companies, Inc. director Walter M. Rosebrough Jr. filed an initial statement of beneficial ownership, reporting indirect control over 10,000 shares of common stock as of 01/03/2026. These shares are held by the Walter M Rosebrough, Jr Revocable Trust, for which he serves as sole trustee, so the position is reported as indirectly owned rather than held in his own name. The filing does not show any recent stock purchase or sale, only the existing ownership position.
Cooper Companies, Inc. (COO) reported insider equity transactions by President & CEO and director Albert G. White III. On 01/08/2026, 18,340 restricted stock units were converted into common stock at an exercise price of $0.00 per share, increasing his directly held common stock to 254,491 shares. On the same date, he disposed of 9,419 common shares at a price of $83.13 per share, leaving 245,072 common shares directly owned after the transactions. Following these events, he also held 36,676 restricted stock units, which vest annually over four years, subject to continued service, with no stated expiration date.
Cooper Companies, Inc. executive Gerard H Warner III reported multiple equity award events on 01/08/2026. As President of CooperVision, Inc., he converted several blocks of restricted stock units into common stock at an exercise price of $0.00 per share, increasing his direct holdings through code M transactions.
On the same date, shares of common stock were withheld in several code F transactions at $83.13 per share, typically used to cover tax obligations on vested awards. After these acquisitions and withholdings, Warner directly owned 23,852 shares of Cooper Companies common stock.
Cooper Companies, Inc. president Holly R. Sheffield reported equity award activity on January 8, 2026. Several blocks of restricted stock units (RSUs) converted to common stock at an exercise price of $0.00, including 3,154 shares, 1,592 shares, and 3,304 shares of common stock. To cover taxes on these vestings, she had 1,462 shares, 738 shares, and 1,641 shares of common stock withheld at a price of $83.13 per share, coded as transaction type “F.”
After these transactions, she directly held 43,261 shares of common stock and 9,462 RSUs. The RSU awards vest in four annual installments of 25% each over four years, with specific schedules described for the 1,592-share, 3,304–3,308-share, and 3,154-share grants, all subject to continued service and with no stated expiration date for the RSUs.
Cooper Companies executive Daniel G. McBride reported multiple equity transactions on 01/08/2026. Several restricted stock unit (RSU) awards were converted into common stock through transaction code M, including 4,168, 4,556, and 4,163 RSUs at an exercise price of $0.00 per share, moving into directly owned common stock. On the same date, he disposed of 2,415, 2,121, and 2,119 shares of common stock at $83.13 per share under transaction code F, leaving 69,352 shares of common stock held directly.
After these transactions, McBride also reported 12,490 RSUs beneficially owned directly. Separately, 94,496 shares of common stock are reported as held indirectly through The McBride Family Trust. Footnotes explain that the RSU awards vest 25% per year over four years, subject to continued service, and that the RSUs have no expiration date and will either vest or be forfeited.
Cooper Companies EVP, CFO & Treasurer Brian G. Andrews reported stock transactions involving restricted stock units and common stock of Cooper Companies, Inc.
On 01/08/2026, 3,528 shares of common stock were acquired at $0.00 per share upon the exercise of restricted stock units, increasing his directly held common stock to 10,430 shares. On the same date, 1,893 shares of common stock were disposed of at $83.13 per share, leaving 8,537 shares of common stock held directly.
Following these transactions, Andrews also had 22,191 shares of common stock held indirectly through the Andrews Family Trust, where he and his spouse are co-trustees, and 7,052 restricted stock units beneficially owned. The RSU award vests 25% per year over four years, with specific share amounts scheduled through 01/08/2028, and will either vest or be forfeited.
Cooper Companies director share purchase: A director of Cooper Companies, Inc. bought 2,000 shares of common stock on 12/17/2025 in an open-market purchase at $82.50 per share. Following this transaction, the director beneficially owns 7,777 shares of Cooper Companies common stock held directly.